US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist
  • 681.580
  • -11.650-1.68%
Close Jan 17 16:00 ET
  • 681.580
  • 0.0000.00%
Post 20:01 ET
74.90BMarket Cap16.86P/E (TTM)

Regeneron Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Regeneron Pharmaceuticals Q4 2024 Estimates Date

Currency：USDFeb 4, 2025

Estimate YoY
Revenue
3.76B
+9.49%
EPS
8.64
-15.23%
Analyst Rating
Buy

Jan 18, 2025

Regeneron Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.543B--
Feb 4, 20252024/Q4-- / 3.760B--
Oct 31, 20242024/Q33.721B / 3.667B--
Aug 1, 20242024/Q23.547B / 3.387B--
May 2, 20242024/Q13.145B / 3.221B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.543B--
Feb 4, 20252024/Q4-- / 3.760B--
Oct 31, 20242024/Q33.721B / 3.667B--
Aug 1, 20242024/Q23.547B / 3.387B--
May 2, 20242024/Q13.145B / 3.221B--

Unlock Free Earnings Estimates

Regeneron Pharmaceuticals Earnings Reports

  • Regeneron Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Oct 31, 2024 07:21 ET

  • Regeneron Pharmaceuticals | 8-K: Regeneron Reports Third Quarter 2024 Financial and Operating Results

    Oct 31, 2024 07:15 ET

  • Regeneron Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 1, 2024 07:21 ET

  • Regeneron Pharmaceuticals | 8-K: Regeneron Reports Second Quarter 2024 Financial and Operating Results

    Aug 1, 2024 07:11 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Hutchmed (China)
    HCM
    +6.61%
    Ermenegildo Zegna NV
    ZGN
    +2.34%
    New Fortress Energy
    NFE
    +2.32%
    Enerpac Tool
    EPAC
    +1.91%
    eBay
    EBAY
    +1.74%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 18, 2025

    Buy

    • Buy

      72.00%

    • Hold

      20.00%

    • Sell

      8.00%

    Price Target

    No Data

    Investment Theme Infectious Disease
    Infectious Disease
    Intraday-0.73%